Robert Auerbach, M.D.

Methotrexate guidelines 2009?
Roenigk, Henry H Jr; Auerbach, Robert; Maibach, Howard I
2010 Aug;63(2):344-345, Journal of the American Academy of Dermatology
— id: 133777, year: 2010, vol: 63, page: 344, stat: Journal Article,

Biological and molecular characterization of a canine hemangiosarcoma-derived cell line
Thamm, Douglas H; Dickerson, Erin B; Akhtar, Nasim; Lewis, Rachel; Auerbach, Robert; Helfand, Stuart C; MacEwen, E Gregory
2006 Aug;81(1):76-86, Research in veterinary science
Canine hemangiosarcoma (HSA) is a devastating disease. Investigation of novel therapies has been limited by the limited availability of canine HSA-derived cell lines. We report the development of a canine HSA-derived cell line, DEN-HSA, which recapitulates features of angiogenic endothelium. DEN-HSA cells were derived from a spontaneous HSA arising in the kidney of a dog. DEN-HSA displayed surface molecules distinctive of endothelial histogenesis, including factor VIII-related antigen, ICAM-1 and alpha(v)beta3 integrin. In vitro, DEN-HSA formed microvascular tube-like structures on Matrigel, and proliferated in response to a variety of angiogenic growth factors. The cells expressed mRNA and protein specific for bFGF and its receptors, and VEGF and its receptors, among others. DEN-HSA conditioned medium evoked a marked angiogenic response in a murine corneal pocket assay, indicating potent proangiogenic activity of substances secreted by this cell line. This research confirms the DEN-HSA cell line as endothelial in origin, suggests the presence of angiogenic growth factor autocrine loops, and offers the potential to utilize DEN-HSA cells for the study of novel therapies that modulate endothelial proliferation
— id: 93961, year: 2006, vol: 81, page: 76, stat: Journal Article,

Angiogenesis assays: a critical overview
Auerbach, Robert; Lewis, Rachel; Shinners, Brenda; Kubai, Louis; Akhtar, Nasim
2003 Jan;49(1):32-40, Clinical chemistry
BACKGROUND: Angiogenesis, the formation of new blood vessels, is an integral part of both normal developmental processes and numerous pathologies, ranging from tumor growth and metastasis to inflammation and ocular disease. Angiogenesis assays are used to test efficacy of both pro- and antiangiogenic agents. METHODS: Most studies of angiogenesis inducers and inhibitors rely on various models, both in vitro and in vivo, as indicators of efficacy. In this report we describe the principal methods now in use: the in vivo Matrigel plug and corneal neovascularization assays, the in vivo/in vitro chick chorioallantoic membrane (CAM) assay, and the in vitro cellular (proliferation, migration, tube formation) and organotypic (aortic ring) assays. We include description of two new methods, the chick aortic arch and the Matrigel sponge assays. CONCLUSIONS: In vitro tests are valuable, can be carried out expeditiously, and lend themselves to quantification, but must be interpreted with extreme caution. In vitro tests are best viewed as providing initial information, subject to confirmation by in vivo assays. Multiple tests should be used to obtain maximum benefit from in vitro tests. In vivo tests are more difficult and time-consuming to perform, thereby limiting the number of tests that can run at any one time. Quantification is generally more difficult as well. However, in vivo assays are essential because of the complex nature of vascular responses to test reagents, responses that no in vitro model can fully achieve
— id: 93962, year: 2003, vol: 49, page: 32, stat: Journal Article,

"Erythema multiforme, Stevens-Johnson, toxic epidermal necrolysis"
Auerbach R; Sanchez M
Current dermatologic diagnosis & treatment Philadelphia : Lippincott Williams & Wilkins, 2001,
— id: 3697, year: 2001, vol: , page: 58, stat: Chapter,

Clinical clearing of psoriasis by 6-thioguanine correlates with cutaneous T-cell depletion via apoptosis: evidence for selective effects on activated T lymphocytes
Murphy FP; Coven TR; Burack LH; Gilleaudeau P; Cardinale I; Auerbach R; Krueger JG
1999 Dec;135(12):1495-1502, Archives of dermatology
BACKGROUND: Psoriasis is a common and persistent disease characterized chiefly by marked epidermal and endothelial cell proliferation and inflammation. These changes are likely a result of activated T lymphocytes infiltrating skin tissue or, in the case of psoriatic arthritis, the joints. OBJECTIVE: To test the hypothesis that the antimetabolite 6-thioguanine (Sigma-Aldrich, St Louis, Mo) might be an effective treatment for psoriasis vulgaris because of its antilymphocytic effects. METHODS: Twenty patients with moderate to severe plaque-type psoriasis were treated with 6-thioguanine for 6 months. The clinical disease was assessed by the psoriasis severity index. Biopsy specimens obtained from lesional skin before treatment and after 1 and 2 months of treatment were examined for disease-related abnormalities using histochemical and computer-assisted image analysis. Antiproliferative effects of 6-thioguanine were compared in human keratinocytes and mitogen-activated lymphocytes over a range of drug concentrations, while viability, cell-cycle, and DNA fragmentation analysis were done using flow cytometry-based assays. RESULTS: After 6 months of treatment, disease severity in 18 of 20 patients showed a significant response to 6-thioguanine: 12 patients were completely cleared of trace disease; 6 showed marked clinical improvement; and 2 did not respond. Patients showed reductions in peripheral blood lymphocytes and total leukocytes, but therapeutic response correlated best with cutaneous T-cell depletion. In vitro assays established that 6-thioguanine has major cytotoxic effects (apparently S-phase specific) on activated T lymphocytes via the induction of apoptosis. Keratinocytes and unactivated T cells, on the other hand, were largely unaffected by incubation with 6-thioguanine. CONCLUSIONS: 6-Thioguanine is effective for the treatment of moderate to severe plaque-type psoriasis, and may be safe when given for defined periods and with careful hematologic monitoring. The mechanism of action of this drug seems to be the induction of apoptosis in activated T lymphocytes
— id: 38332, year: 1999, vol: 135, page: 1495, stat: Journal Article,

Methotrexate in psoriasis: consensus conference
Roenigk HH Jr; Auerbach R; Maibach H; Weinstein G; Lebwohl M
1998 Mar;38(3):478-485, Journal of the American Academy of Dermatology
— id: 57236, year: 1998, vol: 38, page: 478, stat: Journal Article,

Folinic acid to the rescue
Auerbach R
1995 ;3:6-8, Fitzpatrick's journal of clinical dermatology
— id: 38479, year: 1995, vol: 3, page: 6, stat: Journal Article,

UNTITLED
AUERBACH, R
1995 MAY ;21(5):473-473, Dermatologic surgery
— id: 87298, year: 1995, vol: 21, page: 473, stat: Journal Article,

Psoriasis symposium. Methotrexate
Auerbach R
1992 Dec;11(4 Suppl 1):23-29, Seminars in dermatology
— id: 38362, year: 1992, vol: 11, page: 23, stat: Journal Article,

Topical chemotherapy in treatment of skin cancer
Auerbach R
Cancer of the skin Philadelphia : WB Saunders, 1991,
— id: 3106, year: 1991, vol: , page: 466, stat: Chapter,

Histologic evaluation of nail clippings for diagnosing onychomycosis
Suarez SM; Silvers DN; Scher RK; Pearlstein HH; Auerbach R
1991 Oct;127(10):1517-1519, Archives of dermatology
Nail clippings from patients suspected of having onychomycosis were processed for histologic evaluation in the same manner as routine skin with the addition of a chitin-softening solution prior to processing. The sections were stained by the periodic acid-Schiff method and examined for fungal hyphae. The results were compared with the results of fungal cultures from the same nail. Our findings indicate that routine histopathologic analysis of the nail plate alone is a useful complementary method to fungal culture for diagnosing onychomycosis
— id: 38333, year: 1991, vol: 127, page: 1517, stat: Journal Article,

Excision of congenital nevi: immediate, complete, and in the office
Auerbach R
1990 Apr 4;263(13):1768-1768, JAMA
— id: 38349, year: 1990, vol: 263, page: 1768, stat: Journal Article,

Giant keratoacanthoma: an atypical presentation
Edelman BA; Jacobs JB; Rotterdam H; Auerbach R
1990 Sep;103(3):472-475, Otolaryngology, head & neck surgery
— id: 38361, year: 1990, vol: 103, page: 472, stat: Journal Article,

Chemotherapy in psoriasis
Auerbach R
198? ;2:1-5, Mediguide to dermatology
— id: 38481, year: 198?, vol: 2, page: 1, stat: Journal Article,

Acquired reactive perforating collagenosis
Cohen RW; Auerbach R
1989 Feb;20(2 Pt 1):287-289, Journal of the American Academy of Dermatology
— id: 10724, year: 1989, vol: 20, page: 287, stat: Journal Article,

The role of liver biopsies in psoriatic patients receiving long-term methotrexate treatment. Improvement in liver abnormalities after cessation of treatment
Newman M; Auerbach R; Feiner H; Holzman RS; Shupack J; Migdal P; Culubret M; Camuto P; Tobias H
1989 Sep;125(9):1218-1224, Archives of dermatology
Liver biopsy specimens from 168 patients who underwent a total of 364 biopsies were examined. Of 83 patients receiving biopsies before methotrexate treatment, 14 had one or more risk factors predictive of liver abnormality but they had normal pretreatment biopsy specimens. Among 17 patients with abnormal biopsy specimens before methotrexate treatment, only 1 had an identifiable risk factor and 5 had abnormal results of liver function tests. The probability of a normal biopsy specimen after methotrexate treatment dropped below 50% at a cumulative methotrexate dose of 3115 mg for the 31 patients with biopsy specimens from before and after methotrexate treatment and 5776 mg for those who had biopsies only after methotrexate treatment; this difference was statistically significant and is thought to be related to the fact that the patients who had biopsies before and after methotrexate treatment had received most of their medication by the parenteral rather than the oral route. A significant association existed between biopsy grade after methotrexate treatment and obesity. Other risk factors were not correlated with biopsy grade. Blood chemistry tests were not predictive of histopathologic findings. Eight of 11 patients with fibrosis or cirrhosis showed meaningful improvement in liver histologic findings after methotrexate treatment had been withdrawn for 6 months or more; none had progression of abnormalities
— id: 10501, year: 1989, vol: 125, page: 1218, stat: Journal Article,

Methotrexate in psoriasis: revised guidelines
Roenigk HH Jr; Auerbach R; Maibach HI; Weinstein GD
1988 Jul;19(1 Pt 1):145-156, Journal of the American Academy of Dermatology
— id: 38363, year: 1988, vol: 19, page: 145, stat: Journal Article,

REVERSIBILITY OF METHOTREXATE-ASSOCIATED HEPATIC-FIBROSIS
Camuto, P; Newman, M; Culubret, M; Migdal, P; Auerbach, R; Tobias, H; Feiner, H
1987 ;56(Suppl 1):A10-A10, Laboratory investigation
— id: 31287, year: 1987, vol: 56, page: A10, stat: Journal Article,

THE IMPORTANCE OF SERIAL LIVER BIOPSIES IN THE METHOTREXATE TREATMENT OF PSORIASIS
Newman, M; Auerbach, R; Finer, H; Holzman, R; Migdal, P; Culbret, M; Camuto, P; Tobias, H
1987 Sep-Oct;7(5):1088-1088, Hepatology
— id: 31120, year: 1987, vol: 7, page: 1088, stat: Journal Article,

Malignant melanoma in situ in two patients treated with psoralens and ultraviolet A
Marx JL; Auerbach R; Possick P; Myrow R; Gladstein AH; Kopf AW
1983 Dec;9(6):904-911, Journal of the American Academy of Dermatology
Two patients are reported who were treated with 8-methoxypsoralen and ultraviolet A (PUVA) for psoriasis and developed cutaneous lesions of malignant melanoma in situ (atypical melanocytic hyperplasia). One patient received 324.5 joules/cm2 of UVA. Seven months after discontinuing therapy, he developed a superficial spreading melanoma in situ in association with an intradermal nevus on the left posterior thoracic area. The second patient received 2,802 joules/cm of UVA. While on PUVA therapy she developed an in situ lentigo melanoma on her lower lip. To our knowledge only one other psoriatic patient and one patient with vitiligo have developed malignant melanomas after PUVA therapy, so that an increased incidence of malignant melanomas after PUVA therapy, so that an increased incidence of malignant melanoma following PUVA is not documented
— id: 38364, year: 1983, vol: 9, page: 904, stat: Journal Article,

Liver biopsies upsilon liver scans in methotrexate-treated patients with psoriasis
Geronemus RG; Auerbach R; Tobias H
1982 Sep;118(9):649-651, Archives of dermatology
The possibility of hepatotoxic reactions in 24 patients receiving long-term methotrexate therapy for psoriasis was evaluated by both liver biopsies and technetium TC 99 m sulfur-colloid liver scans. The two diagnostic methods were compared in a retrospective analysis. Six of 17 patients with clinically normal liver biopsy interpretations were found to have abnormal liver scans, while three of five patients with histologically proved fibrosis had completely normal liver scans. We conclude that hepatotoxic reactions from long-term methotrexate use in psoriasis cannot be reliably evaluated by the technetium Tc 99m sulfur colloid liver scan.
— id: 9216, year: 1982, vol: 118, page: 649, stat: Journal Article,

Methotrexate guidelines--revised
Roenigk HH Jr; Auerbach R; Maibach HI; Weinstein GD
1982 Feb;6(2):145-155, Journal of the American Academy of Dermatology
— id: 38365, year: 1982, vol: 6, page: 145, stat: Journal Article,

Dyskeratosis congenita and intracranial calcifications
Lieblich LM; Auerbach R; Auerbach AD
1981 Sep;117(9):523-523, Archives of dermatology
— id: 38334, year: 1981, vol: 117, page: 523, stat: Journal Article,

Methotrexate hepatotoxicity in psoriasis. Consideration of liver biopsies at regular intervals
Robinson JK; Baughman RD; Auerbach R; Cimis RJ
1980 Apr;116(4):413-415, Archives of dermatology
Fibrosis of the liver developed to a degree that contraindicated further treatment with methotrexate in 11 of 43 patients who had been receiving maintenance therapy with methotrexate for psoriasis. Liver biopsy had been performed prior to initiation of methotrexate therapy and was repeated at 12- to 18-month intervals. In this retrospective study, age of the patient and duration of therapy have been found to be significant factors in those patients receiving only the weekly oral dosage schedule. Yearly biopsies of the liver are recommended for patients who receive methotrexate throughout their courses of therapy
— id: 38335, year: 1980, vol: 116, page: 413, stat: Journal Article,

Cell Development
Auerbach R
1979 Jan 12;203(4376):163-164, Science
— id: 93963, year: 1979, vol: 203, page: 163, stat: Journal Article,

Plasmapheresis and immunosuppressive therapy. Effect on levels of intercellular antibodies in pemphigus vulgaris
Auerbach R; Bystryn JC
1979 Jun;115(6):728-730, Archives of dermatology
A patient with pemphigus vulgaris and serious side effects of steroid therapy was treated by exchange plasmapheresis. Eight plasmaphereses were performed over six weeks. Each procedure reduced the serum level of intercellular antibodies by 50% to 87%. A rebound in levels of intercellular antibodies usually followed their depletion but could be minimized or completely suppressed by administration of cyclophosphamide. After six weeks of therapy, clinical symptoms had greatly improved and intercellular antibody levels had decreased from a titer of 5,120 to 160. It is not possible to ascribe these improvements specifically to plasmapheresis since the patient was concurrently receiving low doses of prednisone and intermittent treatment with cyclophosphamide
— id: 16286, year: 1979, vol: 115, page: 728, stat: Journal Article,

DYSKERATOSIS CONGENITA - CYTOGENETIC STUDIES IN A FAMILY WITH AN UNUSUAL PATTERN OF INHERITANCE
Auerbach, AD; Lieblich, LM; Ehrenbard, L; Auerbach, R; Chaganti, RSK
1979 ;31(6):A87-A87, American journal of human genetics
— id: 28053, year: 1979, vol: 31, page: A87, stat: Journal Article,

Recurrent pyogenic granuloma with multiple satellites
Pearlstein HH; Auerbach R
1979 July;94:?-?, Consultant
— id: 38478, year: 1979, vol: 94, page: ?, stat: Journal Article,

Hypopigmentation at the site of application of a tourniquet
Testa NN; Waingankar S; Auerbach R
1978 Jun;4(6):473-474, Journal of dermatologic surgery & oncology
Hypopigmentation at a site of application of a tourniquet has not to our knowledge been reported in the literature. We are reporting such a case. We have conjectured that this hypopigmentation may be due to temporary anoxia suffered by melanocytes
— id: 38360, year: 1978, vol: 4, page: 473, stat: Journal Article,

Surgical treatment of baldness by hair transplantation
Auerbach R; Pearlstein HH
1977 Oct;20(4):445-451, Cutis
— id: 38358, year: 1977, vol: 20, page: 445, stat: Journal Article,

A cooperative prospective study of the effects of chemotherapy of psoriasis on liver biopsies
Roenigk HH Jr; Auerbach R; Bergfeld WF; et al
Psoriasis : proceedings of the second international symposium, Stanford University, 1976 New York : Yorke Medical Books, 1977,
— id: 3105, year: 1977, vol: , page: 243, stat: Chapter,

Letter: Hyperlipoproteinaemia and psoriasis
Brustein DM; Scher RK; Auerbach R
1976 Jan 17;1(7951):154-154, Lancet
— id: 16212, year: 1976, vol: 1, page: 154, stat: Journal Article,

Letter: Basal cell carcinoma
Auerbach R
1975 Nov;75(13):2326, 2455-, New York state journal of medicine
— id: 38368, year: 1975, vol: 75, page: 2326, 2455, stat: Journal Article,

Letter: Treatment of lice
Auerbach R
1975 Nov 3;234(5):482-482, JAMA
— id: 38350, year: 1975, vol: 234, page: 482, stat: Journal Article,

A comparison of polyglycolic acid (Dexon), nylon and silk sutures in skin surgery
Auerbach R; Pearlstein MM
1975 Mar;1(1):38-40, Journal of dermatologic surgery
Synthetic polyglycolic acid (Dexon) sutures were compared with silk or nylon in 50 patients requiring skin surgery. After some practice, polyglycolic acid is an easily handled as nylon or silk. Skin reactions occurred in 50% of the patients sutured with nylon, in 10% of those sutured with polyglycolic acid, and in none sutured with silk. Wound healing was satisfactory in all cases
— id: 38372, year: 1975, vol: 1, page: 38, stat: Journal Article,

Letter: Topical application of cyclic AMP in psoriasis
Auerbach R
1974 Jan 21;227(3):326-327, JAMA
— id: 38351, year: 1974, vol: 227, page: 326, stat: Journal Article,

Letter: Immunotherapy for melanoma
Auerbach R
1973 Dec 24;226(13):1571-1571, JAMA
— id: 38352, year: 1973, vol: 226, page: 1571, stat: Journal Article,

Treatment of baldness by hair transplantation
Auerbach R; Pearlstein HH
1973 Feb;70(2):119-122, Journal of the Medical Society of New Jersey
— id: 38371, year: 1973, vol: 70, page: 119, stat: Journal Article,

Ulcerative radiation dermatitis secondary to radon seeds
Auerbach R; Pearlstein HH
1973 Sep 1;73(17):2183-2184, New York state journal of medicine
— id: 38369, year: 1973, vol: 73, page: 2183, stat: Journal Article,

Esophageal stenosis in benign mucous membrane pemphigoid
Minkin W; Seliger G; Auerbach R
1973 May-Jun;82(3):384-385, Annals of otology rhinology & laryngology
— id: 38367, year: 1973, vol: 82, page: 384, stat: Journal Article,

Methotrexate therapy for psoriasis. Guideline revisions
Roenigk HH Jr; Maibach HI; Weinstein GP; [Auerbach R]
1973 Jul;108(1):35-35, Archives of dermatology
— id: 38581, year: 1973, vol: 108, page: 35, stat: Journal Article,

Hepatotoxicity of long-term methotrexate therapy for psoriasis
Tobias H; Auerbach R
1973 Sep;132(3):391-396, Archives of internal medicine
— id: 38359, year: 1973, vol: 132, page: 391, stat: Journal Article,

Psoriasis-liver-methotrexate interactions
[Auerbach R; et al]
1973 Jul;108(1):36-42, Archives of dermatology
— id: 38582, year: 1973, vol: 108, page: 36, stat: Journal Article,

Effect of hydroxyurea and cytarabine on rodent epidermal cells
Auerbach R
1972 Jan;105(1):129-129, Archives of dermatology
— id: 38336, year: 1972, vol: 105, page: 129, stat: Journal Article,

Treatment of the chest keloid
Auerbach R
1972 ;219:?-?, JAMA
— id: 38477, year: 1972, vol: 219, page: ?, stat: Journal Article,

Dermatitis-eczema disorders
Pearlstein HH; Auerbach R
1972 Mar;51(3):80-86, Postgraduate medicine
— id: 38356, year: 1972, vol: 51, page: 80, stat: Journal Article,

Guidelines on methotrexate therapy for psoriasis
Roenigk HH Jr; Maibach HI; Weinstein G; Auerbach R
1972 ;105:363-365, Archives of dermatology
— id: 38476, year: 1972, vol: 105, page: 363, stat: Journal Article,

Photosensitivity and soaps
Auerbach, R; Pearlstein, H H
1971 Apr 1;71(7):747-750, New York state journal of medicine
— id: 38370, year: 1971, vol: 71, page: 747, stat: Journal Article,

Radiation dermatitis secondary to radon needles
Auerbach, R; Pearlstein, H H
1971 Nov 8;218(6):888-888, JAMA
— id: 38353, year: 1971, vol: 218, page: 888, stat: Journal Article,

Punch grafts for burn scar ulcers
Pearlstein HH; Auerbach R
1971 ;8:55-55, Cutis
— id: 38475, year: 1971, vol: 8, page: 55, stat: Journal Article,

Pyoderma and gangreneof the scalp due to improper transplant technique
Pearlstein HH; Auerbach R
1971 ;8:133-133, Cutis
— id: 38474, year: 1971, vol: 8, page: 133, stat: Journal Article,

Mycosis fungoides successfully treated with cyclophosphamide (Cytoxan)
Auerbach R
1970 May;101(5):611-611, Archives of dermatology
— id: 38338, year: 1970, vol: 101, page: 611, stat: Journal Article,

Scleroderma
Auerbach R
1970 May;101(5):612-613, Archives of dermatology
— id: 38337, year: 1970, vol: 101, page: 612, stat: Journal Article,

Chromhidrosis -- a rare dermtaologic entity
Pearlstein HH; Auerbach R
1970 ;141:?-?, Cutis
— id: 38473, year: 1970, vol: 141, page: ?, stat: Journal Article,

Cirrhosis and methotrexate treatment of psoriasis
Auerbach R
1969 Apr 7;208(1):155-155, JAMA
— id: 38354, year: 1969, vol: 208, page: 155, stat: Journal Article,

Methotrexate
Auerbach R
1969 Jul;100(1):121-122, Archives of dermatology
— id: 38339, year: 1969, vol: 100, page: 121, stat: Journal Article,

Newer knowledge of psoriasis
Auerbach R
1969 Dec;46(6):89-91, Postgraduate medicine
— id: 38357, year: 1969, vol: 46, page: 89, stat: Journal Article,

Acne rosacea with fever
Auerbach R; Pearlstein HH; Orentreich N
1969 Jul;100(1):109-109, Archives of dermatology
— id: 16727, year: 1969, vol: 100, page: 109, stat: Journal Article,

Comparative study of two antidandruff preparations
Orentreich N; Taylor EH; Berger RA; Auerbach R
1969 Oct;58(10):1279-1280, Journal of pharmaceutical sciences
— id: 16725, year: 1969, vol: 58, page: 1279, stat: Journal Article,

Alopecia and ichthyosis
Auerbach R
1968 Dec;98(6):682-682, Archives of dermatology
— id: 38340, year: 1968, vol: 98, page: 682, stat: Journal Article,

Low iron levels
Auerbach R
1968 Dec;98(6):681-681, Archives of dermatology
— id: 38341, year: 1968, vol: 98, page: 681, stat: Journal Article,

Alopecia and ichthyosis secondary to allopurinol
Auerbach R; Orentrich N
1968 Jul;98(1):104-104, Archives of dermatology
— id: 38342, year: 1968, vol: 98, page: 104, stat: Journal Article,

Failure of topical testosterone in male-pattern alopecia
Berger RA; Orentreich N; Auerbach R
1968 May 6;204(6):451-452, JAMA
— id: 16733, year: 1968, vol: 204, page: 451, stat: Journal Article,

Basal cell epithelioma of the sole
Berger RA; Auerbach R; Orentreich N
1966 Sep;94(3):317-319, Archives of dermatology
— id: 16736, year: 1966, vol: 94, page: 317, stat: Journal Article,

Anhidrotic effects of adhesive tapes and occlusive film
Orentreich N; Berger RA; Auerbach R
1966 Dec;94(6):709-711, Archives of dermatology
— id: 16735, year: 1966, vol: 94, page: 709, stat: Journal Article,

Fixed drug eruption: ethchlorvynol. Report of a case
Auerbach R
1965 Aug;92(2):184-184, Archives of dermatology
— id: 38331, year: 1965, vol: 92, page: 184, stat: Journal Article,

Growth and behavior of cultured human epidermal cells implanted in homologous skin
Van Scott EJ; Auerbach R; Evans VJ
1965 Jul;35(1):175-183, Journal of the National Cancer Institute
— id: 38375, year: 1965, vol: 35, page: 175, stat: Journal Article,

PARENTERAL VS. ORAL FOLIC ACID ANTAGONISTS
AUERBACH R
1964 Dec;90(3):553-557, Archives of dermatology
— id: 38343, year: 1964, vol: 90, page: 553, stat: Journal Article,

COMPARISON OF THE POTENCY OF POISON IVY EXTRACTS WITH SYNTHETIC PENTADECYLCATECHOL IN SENSITIVE HUMANS
AUERBACH R; BAER H
1964 May-Jun;35:201-205, Journal of allergy & clinical immunology
— id: 38376, year: 1964, vol: 35, page: 201, stat: Journal Article,

DIAGNOSIS: PSORIASIS AND PSORIATIC ARTHROPATHY TREATED WITH METHOTREXATE ADMINISTERED INTRAVENOUSLY
AUERBACH R; ORENTREICH N; BERGER R
1964 Jul;90(3):115-116, Archives of dermatology
— id: 38344, year: 1964, vol: 90, page: 115, stat: Journal Article,

METHOTREXATE THERAPY IN PSORIATIC ARTHRITIS; DOUBLE-BLIND STUDY ON 21 PATIENTS
BLACK RL; O'BRIEN WM; VANSCOTT EJ; AUERBACH R; EISEN AZ; BUNIM JJ
1964 Sep 7;189(6):743-747, JAMA
— id: 38355, year: 1964, vol: 189, page: 743, stat: Journal Article,

TRAUMATIC CALCIUM DEPOSITION IN SKIN
CLENDENNING WE; AUERBACH R
1964 Mar;89(3):360-363, Archives of dermatology
— id: 38346, year: 1964, vol: 89, page: 360, stat: Journal Article,

PARENTERAL METHOTREXATE IN PSORIASIS
VANSCOTT EJ; AUERBACH R; WEINSTEIN GD
1964 Apr;89(3):550-556, Archives of dermatology
— id: 38345, year: 1964, vol: 89, page: 550, stat: Journal Article,

Occupational ultraviolet light and skin disease. Two case reports
AUERBACH R; WEINSTEIN GD
1963 Jun;87(3):691-692, Archives of dermatology
— id: 38347, year: 1963, vol: 87, page: 691, stat: Journal Article,

Keratoacanthomata in generalized pustular psoriasis
CLENDENNING WE; AUERBACH R
1963 ;43:68-75, Acta dermato-venereologica
— id: 38377, year: 1963, vol: 43, page: 68, stat: Journal Article,

DETERMINANTS OF RATE AND KINETICS OF CELL DIVISION IN SCALP HAIR
VANSCOTT EJ; EKEL TM; AUERBACH R
1963 Nov;41(1):269-273, Journal of investigative dermatology
— id: 38373, year: 1963, vol: 41, page: 269, stat: Journal Article,

Treatment of mycosis fungoides with cyclophosphamide
VAN SCOTT EJ; AUERBACH R; CLENDENNING WE
1962 Apr;85(3):499-501, Archives of dermatology
— id: 38348, year: 1962, vol: 85, page: 499, stat: Journal Article,

Studies on the location of the receptor sites in cutaneous axon reflexes
AUERBACH R; PEARSON RW; LORINCZ AL
1960 Dec;35(1):343-345, Journal of investigative dermatology
— id: 38374, year: 1960, vol: 35, page: 343, stat: Journal Article,

Toxic epidermal necrolysis. Acute pemphigus
POTTER B; AUERBACH R; LORINCZ AL
1960 Dec;82:903-907, Archives of dermatology
— id: 38366, year: 1960, vol: 82, page: 903, stat: Journal Article,